Stay updated on Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedSite revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check54 days agoChange DetectedThe update is a minor revision from v3.4.1 to v3.4.2 with no visible user-facing changes to the study details on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded Revision: v3.4.1; removed the funding-lapse notice and Revision: v3.4.0.SummaryDifference0.3%

- Check76 days agoChange DetectedAdded a glossary toggle and updated metadata to display Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check83 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4 with no user-visible changes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.